Literature DB >> 12636251

Lactoferrin feeding augments peritoneal macrophage activities in mice intraperitoneally injected with inactivated Candida albicans.

Hiroyuki Wakabayashi1, Natsuko Takakura, Susumu Teraguchi, Yoshitaka Tamura.   

Abstract

Oral administration of lactoferrin (LF), an innate-defense protein present in exocrine secretions such as milk and in neutrophils, is reported to improve host-protection against infections with microorganisms including pathogenic fungi, possibly due to an immunomodulatory effect. This study aimed to evaluate the effect of bovine LF feeding on peritoneal macrophage activities in mice intraperitoneally injected with inactivated Candida albicans. Time course analysis during the 14 days following Candida-priming revealed that LF administration slightly increased the number of peritoneal exudate cells, and significantly enhanced the production of superoxide anion (O2(-)) and nitric oxide (NO) by peritoneal macrophages at day 7. LF administration facilitated NO production and Candida hyphal-growth inhibition by macrophages derived from Candida-primed mice but not non-primed mice, suggesting that the action of LF is dependent on the immune status of the host. LF administration altered the kinetics of cytokines in the peritoneal lavage fluid of Candida-primed mice. Enhancement of cytokine levels by LF was observed for IL-12 at day 5 and IFN-gamma at day 9, but not for TNF-alpha or IL-10. In conclusion, LF feeding augmented the activities of macrophages in a manner dependent on Candida-priming and these effects may be related to enhanced cytokine levels.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12636251     DOI: 10.1111/j.1348-0421.2003.tb02783.x

Source DB:  PubMed          Journal:  Microbiol Immunol        ISSN: 0385-5600            Impact factor:   1.955


  10 in total

1.  Oral lactoferrin protects against experimental candidiasis in mice.

Authors:  K Velliyagounder; W Alsaedi; W Alabdulmohsen; K Markowitz; D H Fine
Journal:  J Appl Microbiol       Date:  2014-11-25       Impact factor: 3.772

Review 2.  Lactoferrin--a novel bone growth factor.

Authors:  Dorit Naot; Andrew Grey; Ian R Reid; Jillian Cornish
Journal:  Clin Med Res       Date:  2005-05

3.  Recombinant human lactoferrin modulates human PBMC derived macrophage responses to BCG and LPS.

Authors:  Shen-An Hwang; Marian L Kruzel; Jeffrey K Actor
Journal:  Tuberculosis (Edinb)       Date:  2016-09-28       Impact factor: 3.131

Review 4.  Lactoferrin as a natural immune modulator.

Authors:  Jeffrey K Actor; Shen-An Hwang; Marian L Kruzel
Journal:  Curr Pharm Des       Date:  2009       Impact factor: 3.116

5.  Modulation of immunity-related gene expression in small intestines of mice by oral administration of lactoferrin.

Authors:  Hiroyuki Wakabayashi; Natsuko Takakura; Koji Yamauchi; Yoshitaka Tamura
Journal:  Clin Vaccine Immunol       Date:  2006-02

6.  Oral administration of bovine whey proteins to mice elicits opposing immunoregulatory responses and is adjuvant dependent.

Authors:  A O Afuwape; M W Turner; S Strobel
Journal:  Clin Exp Immunol       Date:  2004-04       Impact factor: 4.330

7.  Novel nanoscale bacteriophage-based single-domain antibodies for the therapy of systemic infection caused by Candida albicans.

Authors:  Shuai Dong; Hongxi Shi; Donghui Cao; Yicun Wang; Xintong Zhang; Yan Li; Xiang Gao; Li Wang
Journal:  Sci Rep       Date:  2016-08-25       Impact factor: 4.379

8.  The Preventive Effect of Lactoferrin-Containing Yogurt on Gastroenteritis in Nursery School Children-Intervention Study for 15 Weeks.

Authors:  Teruomi Tsukahara; Anri Fujimori; Yuka Misawa; Hirotsugu Oda; Koji Yamauchi; Fumiaki Abe; Tetsuo Nomiyama
Journal:  Int J Environ Res Public Health       Date:  2020-04-07       Impact factor: 3.390

9.  Safety and tolerability of the antimicrobial peptide human lactoferrin 1-11 (hLF1-11).

Authors:  Walter J F M van der Velden; Thijs M P van Iersel; Nicole M A Blijlevens; J Peter Donnelly
Journal:  BMC Med       Date:  2009-09-08       Impact factor: 8.775

10.  Role of bacterial lipopolysaccharide in enhancing host immune response to Candida albicans.

Authors:  Helen Rogers; David W Williams; Gui-Jie Feng; Michael A O Lewis; Xiao-Qing Wei
Journal:  Clin Dev Immunol       Date:  2013-01-21
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.